⌘K

Login Start Free

Home/Filings/4/0001213900-17-007153

4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001213900-17-007153

$ORMPCIK 0001176309operating

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 3:36 PM ET

Size

5.5 KB

Accession

0001213900-17-007153

Insider Transaction Report

Form 4

Period: 2017-06-30

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Award
Stock Option (right to buy)
2017-06-30+16,773→ 16,773 total
Exercise: $7.77Exp: 2027-06-30→ Common Stock (16,773 underlying)

Footnotes (1)

[F1]The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019.

Documents

1 file

4
f4063017friedman_oramed.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001176309

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 3:36 PM ET
Size: 5.5 KB

View on SEC.gov